- RIUMA Principal
- Listar por autor
Listar por autor "Cubero, Francisco Javier"
Mostrando ítems 1-5 de 5
-
Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
Atallah, Edmond; Freixo, Cristiana; Alvarez-Alvarez, Ismael; Cubero, Francisco Javier; Gerbes, Alexander L; Kullak-Ublick, Gerd A; Aithal, Guruprasad P.[et al.] (Taylor & Francis, 2021-11-15)Introduction: Idiosyncratic drug-induced liver injury (DILI) is an unpredictable event, and there are no specific biomarkers that can distinguish DILI from alternative explanations or predict its clinical outcomes. Areas ... -
Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network
Segovia-Zafra, Antonio; Villanueva-Paz, Marina; Serras, Ana Sofía; Matilla-Cabello, Gonzalo; Bodoque-García, Ana; Di Zeo-Sánchez, Daniel Enrique; Niu, Hao; Álvarez-Álvarez, Ismael; Sanz-Villanueva, Laura; Godec, Sergej; Milisav, Irina; Bagnaninchi, Pierre; Andrade, Raúl J.; Lucena, M. Isabel; Fernandez-Checa, J.C.; Cubero, Francisco Javier; Paiva Miranda, Joana; Nelson, Leonard J.[et al.] (Elsevier, 2024)Background & Aims Idiosyncratic drug-induced liver injury (DILI) is a complex and unpredictable event caused by drugs, and herbal or dietary supplements. Early identification of human hepatotoxicity at preclinical stages ... -
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen
Rodríguez-Agudo, Rubén; Goikoetxea-Usandizaga, Naroa; Serrano-Maciá, Marina; Fernández-Tussy, Pablo; Fernández-Ramos, David; Lachiondo-Ortega, Sofía; González-Recio, Irene; Gil-Pitarch, Clàudia; Mercado-Gómez, María; Bizkarguenaga, Maider; Lopitz-Otsoa, Fernando; Petrov, Petar; Bravo, Miren; Martijn Van Liempd, Sebastiaan; Falcón-Pérez, Juan Manuel; Zabala-Letona, Amaia; Carracedo, Arkaitz; Vicente Castell, Jose; Jover, Ramiro; Martínez-Cruz, Luis Alfonso; Cardoso Delgado, Teresa; Cubero, Francisco Javier; Lucena-González, María Isabel; Andrade-Bellido, Raúl Jesús; Mabe, Jon; Simón, Jorge; Martínez-Chantar, María Luz[et al.] (IOAP-MPDI, 2022-04-30)Drug-induced liver injury (DILI) development is commonly associated with acetaminophen (APAP) overdose, where glutathione scavenging leads to mitochondrial dysfunction and hepatocyte death. DILI is a severe disorder without ... -
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
Villanueva-Paz, Marina; Morán, Laura; López-Alcántara, Nuria; Freixo, Cristiana; Andrade-Bellido, Raúl Jesús; Lucena-González, María Isabel; Cubero, Francisco Javier[et al.] (MDPI, 2021-03-05)Idiosyncratic drug-induced liver injury (DILI) is a type of hepatic injury caused by an uncommon drug adverse reaction that can develop to conditions spanning from asymptomatic liver laboratoryabnormalitiestoacuteliverfa ... -
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
Lucena-González, María Isabel; Villanueva-Paz, Marina; Alvarez-Alvarez, Ismael; Aithal, Guruprasad P.; Bjornsson, Einar S.; Cakan-Akdogan, G.; Cubero, Francisco Javier; Esteves, Freddy; Falcón-Pérez, Juan Manuel; Fromenty, B.; Garcia-Ruiz, C.; Grove, J.I.; Konu, O.; Kranendonk, M.; Kullak-Ublick, Gerd A; Miranda, J.P.; Remesal-Doblado, A.; Sancho-Bru, P.; Nelson, L.; Andrade-Bellido, Raúl Jesús; Fernandez-Checa, J.C.[et al.] (Elsevier, 2023-12-28)In the current article the aims for a constructive way forward in Drug-Induced Liver Injury (DILI) are to highlight the most important priorities in research and clinical science, therefore supporting a more informed, ...